"The U.S. Food and Drug Administration recently approved Oralair to treat allergic rhinitis (hay fever) with or without conjunctivitis (eye inflammation) that is induced by certain grass pollens in people ages 10 through 65 years. Oralair is the f"...
PATADAY™ (olopatadine hydrochloride ophthalmic solution) solution is indicated for the treatment of ocular itching associated with allergic conjunctivitis.
Dosage Forms And Strengths
Ophthalmic solution 0.2%: each ml contains 2.22 mg of olopatadine hydrochloride.
Storage And Handling
PATADAY™ (olopatadine hydrochloride ophthalmic solution) 0.2% is supplied in a white, oval, low density polyethylene DROP-TAINER® dispenser with a natural low density polyethylene dispensing plug and a white polypropylene cap. Tamper evidence is provided with a shrink band around the closure and neck area of the package.
2.5 mL fill in 4 mL bottle (NDC 0065-027225)
Store at 2°C to 25°C (36°F to 77°F)
Manufacturer details: n/a. Revised: 8/2010This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 1/27/2011
Additional Pataday Information
Pataday - User Reviews
Pataday User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.